RQA's digest of the joint regulator symposium on Good Clinical Practice, Bioequivalence and Pharmacovigilance, held 2–4 June 2026.
Twenty-five sessions distilled into searchable briefings, with each regulator's position set out side by side. Enter your email to access the material.
Member-only briefings from the joint US Food and Drug Administration (FDA), UK Medicines and Healthcare products Regulatory Agency (MHRA) and Health Canada conference on Good Clinical Practice, Bioequivalence and Good Pharmacovigilance Practice.
A register of the conference's 15 sub-topics against its three days. Each cell counts the sessions that touched a sub-topic that day — the darker the block, the heavier the coverage. It answers the question a QA professional actually asks: when is my topic covered, and how heavily. Click a cell to browse those sessions; click a sub-topic to open its theme record.
The conference drawn as a schematic plate. Hollow navy rings are the 15 sub-topics; solid ink squares are the 25 sessions; hairlines link each session to every theme it touched. Sessions that share themes settle near one another; themes with many sessions become hubs. Hover a node to trace its links. Click a session to open its record, or a theme to open the theme index.
Pick a route that matches your role or your goal. Each is a curated 4–6 session journey through the conference — designed for skim-reading on Monday morning, deep-reading by Friday.
Every acronym used across the 25 sessions, alphabetised and de-duplicated. Click a session number under any entry to jump to where it appeared.
Cross-cutting briefings show what FDA, MHRA and Health Canada each said about a single theme — side by side. Useful when you want the regulator picture on one topic without watching every session.
Ask anything about the conference. Answers are grounded in the session transcripts and cite the source session number.
Examples to try: